Severe steroid-resistant post-infectious encephalomyelitis: General features and effects of IVIg

Journal of Neurology

Volumn 254, Issue 11, 2007, Pages 1518-1523

  Ravaglia, S ^a   Piccolo, G ^a   Ceroni, M ^a   Franciotta, D ^a   Pichiecchio, A ^a   Bastianello, S ^a   Tavazzi, E ^a   Minoli, L ^b   Marchioni, E ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

ADEM; Encephalomyelitis; Intravenous immunoglobulins; Myelo radiculo nevritis

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; ENCEPHALOMYELITIS; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; MALE; POSTINFECTION ENCEPHALITIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; STEROID THERAPY; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STEROIDS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 36348972323     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-007-0561-4     Document Type: Article

References (23)

1. Menge T, Hemmer B, Nessier B, et al. (2005) Acute disseminated encephalomyelitis. An update. Arch Neurol 62:1673-1680
2. Wingerchuk DM (2003) Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep 3(3):256-264
3. al Deeb SM, Yaqub BA, Bruyn GW, Biary NM (1997) Acute transverse myelitis.A localized form of postinfectious encephalomyelitis. Brain. 120 (Pt 7):1115-1122
4. Aimoto Y, Moriwaka F, Matsumoto A, Tashiro K, Abe K (1996) A case of acute disseminated encephalomyelitis (ADEM) associated with demyelinating peripheral neuropathy. No To Shinkei 48(9):857-860
5. Amit R, Glick B, Itzchak Y, Dgani Y, Meyeir S (1992) Acute severe combined demyelination. Childs Nerv Syst 8(6):354-356
6. Dowling PC, Bosh VV, Cook SD (1980) Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology 30(2):33-36
7. Ellis BD, Kosmorsky GS, Cohen BH (1994) Medical and surgical management of acute disseminated encephalomyelitis. J.Neuro-Ophthalmol 14(4):210-213
8. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G (2000) Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 28; 54(6):1370-1372
9. Kanter DS, Horensky D, Sperling RA, Kaplan JD, Malachowski ME, Churchill WH Jr (1995) Plasmapheresis in fulminant acute disseminated encephalomyelitis. Neurology 45(4):824-827
10. Murthy K, Faden HS, Cohen ME, Bakshi R (2002) Acute disseminated encephalomyelitis in children. Pediatrics 110(2 Pt 1):e21
11. Hahn JS, Siegler DJ, Enzmann D (1996) Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 46(4):1173-1174
12. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S (1999) Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol 21:583-586
13. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. (2002) Effectiveness of intravenous immunoglobulin treatment in adult patients with steroidresistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 249:100-104
14. Andersen O (2000) Myelitis. Curr Opin Neurol 13(3):311-316
15. Uehara A, Okamoto Y, Nishitarumizu K, et al. (2002) A patient with ADEM and central and peripheral conduction block improved with ultra-high-dose methylprednisolone. Rinsho Shinkeigaku 42(3):237-239
16. Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N (2002) Outcome of severe encephalomyelitis in children: effects of high-dose methylprednisolone and immunoglobulins. J Child Neurol 17:810-814
17. Predhan S, Gupta RP, Shashank S, Pandey N (1999) Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 165(1):56-61
18. Finsterer J, Grass R, Stollberger C, Mamoli B (1998) Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis. Clin Neuropharmacol 21(4):258-261
19. Marchioni E, Ravaglia S, Piccolo G, et al. (2005) Post-infectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 11; 65(7):1057-1065
20. Koziol JA, Lucero A, Sipe JC, Romine JS, Beutler E (1999) Responsiveness of the Scripps neurologic rating scale during a multiple sclerosis clinical trial. Can J Neurol Sci 26(4):283-289
21. Kurtzke JF (1970) Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand 46:493-512
22. Dalakas MC (2002) Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 59(Suppl. 6):S13-S21
23. nd ed), Butterworth- Heinemann,Newman, pp 1307-1343